Limited usefulness of the free-to-total prostate-specific antigen ratio for the diagnosis and staging of prostate cancer in Japanese men

By Sakai Iori   Harada Ken-ichi   Hara Isao   Eto Hiroshi   Miyake Hideaki  

International Journal of Clinical Oncology, Vol. 9, Iss. 1, 2004-02 ,pp. : 64-67

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Evaluation of Free PSA/Total PSA (Prostate-specific Antigen) Ratio in the Diagnosis of Prostate Cancer

By Filella X.   Alcover J.   Molina R.   Rodriguez A.   Carretero P.   Ballesta A.M.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1226-1229

Elsevier

Access to resources Recommend Favorite

The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA

By Grossklaus D.J.   Smith J.A.   Shappell S.B.   Coffey C.S.   Chang S.S.   Cookson M.S.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 5, 2002-09 ,pp. : 195-198

Elsevier

Access to resources Recommend Favorite

Prostate-specific antigen

By Stenman U-H.   Leinonen J.   Zhang W-M.   Finne P.  

Seminars in Cancer Biology, Vol. 9, Iss. 2, 1999-04 ,pp. : 83-93

Academic Press

Access to resources Recommend Favorite

18F-fluorodeoxyglucose PET/CT for detection of disease in patients with prostate-specific antigen relapse following radical treatment of a local-stage prostate cancer

By    

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 316-322

Spandidos Publications

Access to resources Recommend Favorite